How severe is CVE-2023-27871?

CVE-2023-27871 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2023-27871 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (55th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-27871?

CVE-2023-27871 primarily affects Ibm Aspera Faspex. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2023-27871?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-27871 published?

CVE-2023-27871 was published on 2023-03-21 and last updated on 2026-06-17.

CVE-2023-27871

CVE-2023-27871 is a high-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Severity: High (CVSS 3.x base score 7.5)
EPSS exploit prediction: 1% (55th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-89
Affected product: Ibm Aspera Faspex
Published: 2023-03-21
Last modified: 2026-06-17

Description

IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user, using a specially crafted SQL query. IBM X-Force ID: 249613.

Frequently asked questions

What is CVE-2023-27871?: IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user, using a specially crafted SQL query. IBM X-Force ID: 249613.
How severe is CVE-2023-27871?: CVE-2023-27871 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2023-27871 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (55th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-27871?: CVE-2023-27871 primarily affects Ibm Aspera Faspex. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-27871?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-27871 published?: CVE-2023-27871 was published on 2023-03-21 and last updated on 2026-06-17.

References

Affected products (3)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_faspex:4.4.2:patch_level_1:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_faspex:4.4.2:patch_level_2:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…
CVE-2022-22497 — High (CVSS 7.5): IBM Aspera Faspex 4.4.1 and 5.0.0 could allow unauthorized access due to an incorrectly computed security token. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-89 (SQL Injection) vulnerabilities

CVE-2026-54350 — Critical (CVSS 10.0): Budibase is an open-source low-code platform. Prior to 3.39.12, an unauthenticated visitor of any published Budibase…
CVE-2026-8054 — Critical (CVSS 10.0): Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') in the Publish Audit API endpoints…
CVE-2026-42287 — Critical (CVSS 10.0): Emlog is an open source website building system. Prior to version 2.6.11, direct SQL injection in article creation and…
CVE-2026-3325 — Critical (CVSS 10.0): SQL injection (SQLi) in MegaCMS v12.0.0, specifically in the “id_territorio” parameter of the…
CVE-2025-10878 — Critical (CVSS 10.0): A SQL injection vulnerability exists in the login functionality of Fikir Odalari AdminPando 1.0.1 before 2026-01-26.…
CVE-2025-57792 — Critical (CVSS 10.0): Explorance Blue versions prior to 8.14.9 contain a SQL injection vulnerability caused by insufficient validation of…

Browse all CWE-89 (SQL Injection) vulnerabilities →